Načítá se...
Systemic Allergic Reaction to the GLP-1 Receptor Agonist Exenatide
Objective: To report a case of systemic hypersensitivity to the glucagon-like peptide-1 (GLP-1) receptor agonist exenatide used in diabetes care to provide significant information within the context of postmarketing safety surveillance of this new drug class. Case Summary: We report on a 52-year-old...
Uloženo v:
| Vydáno v: | J Pharm Technol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5990155/ https://ncbi.nlm.nih.gov/pubmed/34860904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122514539462 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|